Impact of Admission, Fasting Glucose and HbA1c Levels on in-stent Restenosis in The Patients Treated with Primary Percutaneous Coronary Intervention in 5-Year Follow-up

Basit Öğe Kaydı
dc.contributor.authorKaradeniz, Fatma Ozpamuk
dc.contributor.authorKaradeniz, Yusuf
dc.contributor.authorGungor, Baris
dc.contributor.authorEren, Mehmet
dc.date.accessioned2024-02-23T14:38:08Z
dc.date.available2024-02-23T14:38:08Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractAim: Despite advances in-stent technology, in-stent restenosis (ISR) is still a major problem following percutaneous coronary intervention (PCI) and its reasons have not been fully revealed. In the presented study, we investigated the effect of admission blood glucose (ABG), fasting blood glucose (FBG) and glycated hemoglobin A1c (HbA1c) levels on coronary ISR patients with ST-elevation myocardial infarction (STEMI) who underwent primary PCI in five-year follow-up. Methods: From 2.900 patients who underwent coronary stent implantation for STEMI from January 2008 through December 2012 were retrospectively analyzed through the hospital digital recording system. Of these, 264 patients who underwent control coronary angiography during the five-year follow-up were included in the study. Patients were divided into two main group ISR and non-ISR; were divided into two subgroups diabetic and non-diabetic groups were compared with HbA1c, ABG, FBG and angiographic parameters. Results: There were 127 patients in the ISR group (diabetic: 36 non-diabetic: 91) and 137 patients in the non-ISR group (diabetic: 43 non-diabetic: 94). Regardless of the patients diabetes status, no significant difference was found between the groups with and without ISR in terms of HbA1c, FBG and ABG. A significant relationship was found between the baseline HbA1c value and having ISR only in the diabetic subgroup (p=0.01). Conclusion: This study results showed that in diabetic STEMI patients who underwent primary PCI, higher HbA1c levels were associated with higher ISR rates, but not with FBG and ABG levels.en_US
dc.identifier.doi10.4274/haseki.galenos.2021.6872
dc.identifier.endpage90en_US
dc.identifier.issn1302-0072
dc.identifier.issn2147-2688
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85101281297en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage85en_US
dc.identifier.urihttps://doi.org/10.4274/haseki.galenos.2021.6872
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16367
dc.identifier.volume59en_US
dc.identifier.wosWOS:000658757400015en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofHaseki Tip Bulteni-Medical Bulletin Of Hasekien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSt Elevation Myocardial Infarctionen_US
dc.subjectBlood Glucoseen_US
dc.subjectGlycated Hemoglobin A1cen_US
dc.subjectPercutaneous Coronary Interventionen_US
dc.subjectCoronary Angiographyen_US
dc.subjectCoronary Restenosisen_US
dc.subjectDiabetes Mellitusen_US
dc.titleImpact of Admission, Fasting Glucose and HbA1c Levels on in-stent Restenosis in The Patients Treated with Primary Percutaneous Coronary Intervention in 5-Year Follow-upen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu